Ryuji Ueno
Founder at S&R Foundation
Profile
Ryuji Ueno is an entrepreneur and businessperson who founded 6 companies, notably: Sucampo Pharmaceuticals, Inc., R-Tech Ueno, Ltd.
and Sucampo GmbH and who has been at the head of 5 different companies.
Currently, Dr. Ueno occupies the position of Chairman & Chief Medical Officer at VLP Therapeutics LLC (which he founded in 2012), President at Omotesenke Domonkai Eastern Region USA, Inc. and Managing Member at S&R Technology Holdings LLC (which he founded in 1999).
He is also on the board of S&R Foundation.
In the past Ryuji Ueno occupied the position of Chief Executive & Scientific Officer at Sucampo Pharmaceuticals, Inc. (he founded the company in 1996) and Chairman & Chief Executive Officer at Sucampo GmbH (he founded the company in 2010).
He received a doctorate from Keio University and a doctorate from Osaka University.
Ryuji Ueno active positions
Companies | Position | Start |
---|---|---|
S&R Foundation
S&R Foundation Miscellaneous Commercial ServicesCommercial Services The S&R Foundation provides support for artists and scientists involved in the arts, sciences, and social entrepreneurship, especially those furthering international and cultural collaboration. The company was founded by Sachiko Kuno and Ryuji Euno in 2000 and is headquartered in Washington, DC. | Founder | 1999-12-31 |
Omotesenke Domonkai Eastern Region USA, Inc. | President | - |
S&R Technology Holdings LLC
S&R Technology Holdings LLC Financial ConglomeratesFinance S&R Technology Holdings LLC provide support to global entrepreneurs and new businesses. It offers managing and growing global ventures. The company was founded by Sachiko Kuno and Ryuji Ueno in 1999 and is headquartered in Bethesda, MD. | Founder | 1998-12-31 |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Founder | 2011-12-31 |
Former positions of Ryuji Ueno
Companies | Position | End |
---|---|---|
SUCAMPO PHARMACEUTICALS, INC. | Chief Executive Officer | 2014-03-02 |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss pharmaceutical company that manufactures and distributes healthcare products. The private company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals, Inc., part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Chief Executive Officer | 2014-03-02 |
R-TECH UENO, LTD. | Founder | 2002-12-31 |
Training of Ryuji Ueno
Keio University | Doctorate Degree |
Osaka University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
R-Tech Ueno, Ltd.
R-Tech Ueno, Ltd. Pharmaceuticals: MajorHealth Technology R-Tech Ueno Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. It operates through the following business divisions: New Pharmaceutical Research and Development, Pharmaceutical Manufacture and Sale, and Pharmaceutical Development Support and Contract Manufacturing Services. The New Pharmaceutical Research and Development business provides development for unmet medical needs area, orphan drug area, and anti-aging area. The Pharmaceutical Manufacture and Sale business handles the manufacture and sale of Rescula Eye Drops for glaucoma and ocular hypertension. The Pharmaceutical Development Support and Contract Manufacturing Services business covers the manufacture and sale of AMITIZA capsules for chronic idiopathic constipation. It also accepts contract manufacturing of eye drops, liquid drugs and liquid-filled hard capsules. The company was founded by Ryuji Ueno and Sachiko Kuno in September 1989 and is headquartered in Tokyo, Japan. | Health Technology |
S&R Technology Holdings LLC
S&R Technology Holdings LLC Financial ConglomeratesFinance S&R Technology Holdings LLC provide support to global entrepreneurs and new businesses. It offers managing and growing global ventures. The company was founded by Sachiko Kuno and Ryuji Ueno in 1999 and is headquartered in Bethesda, MD. | Finance |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss pharmaceutical company that manufactures and distributes healthcare products. The private company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals, Inc., part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Health Technology |
S&R Foundation
S&R Foundation Miscellaneous Commercial ServicesCommercial Services The S&R Foundation provides support for artists and scientists involved in the arts, sciences, and social entrepreneurship, especially those furthering international and cultural collaboration. The company was founded by Sachiko Kuno and Ryuji Euno in 2000 and is headquartered in Washington, DC. | Commercial Services |
Omotesenke Domonkai Eastern Region USA, Inc. | |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Commercial Services |